Group 1: Financial Performance - The company reported a loss in Q1 2023 due to weak downstream demand, global inflation, geopolitical conflicts, and a decline in order volume compared to the previous year [1] - The average product prices have significantly decreased compared to the same period last year, impacting profitability [1] - The company is adjusting its production capacity structure in Inner Mongolia, with some products entering trial production, which has not yet effectively released capacity [1] Group 2: Business Strategy and Development - The company aims to become a leading supplier of light-curing new materials and application system solutions, focusing on the development of new photoinitiators and sulfur-containing fine chemicals [2] - The strategic plan includes three main areas: developing new photoinitiator products, innovating synthesis techniques in sulfur fine chemicals, and focusing on phosphorus-containing intermediates [2] - The company is actively expanding its upstream and downstream supply chains to achieve win-win cooperation [2] Group 3: Market Conditions and Risks - The radiation curing industry is currently in a cyclical downturn, with weak downstream demand affecting the company's photoinitiator business in the short term [3] - The company faces various risks, including macroeconomic and policy risks, production project risks, technological innovation risks, and raw material price fluctuations [3] - The export revenue accounted for 20%-30% of the company's total revenue in the past two years, but has decreased due to global economic downturns and geopolitical issues [3] Group 4: Operational Adjustments - The company is implementing measures to manage raw material cost fluctuations by adjusting production based on historical price trends and optimizing inventory levels [3] - The Inner Mongolia production capacity has not been effectively released due to weak downstream demand, but the company plans to rationally adjust its overall capacity structure [3] - The company is committed to improving production efficiency and reducing unit production costs to support global marketing and business expansion [3]

Financial Performance - The company's revenue for Q1 2023 was ¥158,164,544.68, a decrease of 31.54% compared to ¥231,037,818.81 in the same period last year[5] - The net profit attributable to shareholders was a loss of ¥15,037,349.28, representing a decline of 229.47% from a profit of ¥11,614,748.46 in the previous year[5] - Basic and diluted earnings per share were both negative at ¥-0.0641, down 229.49% from ¥0.0495 in the previous year[5] - Total operating revenue for Q1 2023 was ¥158,164,544.68, a decrease of 31.5% compared to ¥231,037,818.81 in Q1 2022[21] - Net profit for Q1 2023 was a loss of ¥15,037,349.28, compared to a profit of ¥11,614,748.46 in Q1 2022[23] - Basic and diluted earnings per share for Q1 2023 were both -¥0.0641, compared to ¥0.0495 in Q1 2022[24] Cash Flow and Liquidity - The net cash flow from operating activities was negative at ¥6,725,878.10, a decrease of 122.22% compared to ¥30,266,165.35 in the same period last year[5] - Operating cash flow for the current period was -6,725,878.10, a decrease from 30,266,165.35 in the previous period, indicating a significant decline in operational performance[25] - Cash inflow from operating activities totaled 124,376,654.05, down 38% from 200,465,190.32 in the previous period[25] - Cash outflow from operating activities increased to 131,102,532.15, compared to 170,199,024.97 in the previous period, reflecting a tighter cash management[25] - The ending cash and cash equivalents balance was 76,740,907.40, down from 86,043,976.30 in the previous period, indicating a decrease in liquidity[26] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,407,873,446.26, an increase of 1.33% from ¥1,389,429,540.68 at the end of the previous year[5] - The company's total liabilities increased to ¥657,377,892.29 in Q1 2023 from ¥632,139,067.83 in Q1 2022, reflecting a rise of 4.0%[20] - The total equity attributable to shareholders decreased to ¥750,495,553.97 in Q1 2023 from ¥757,290,472.85 in Q1 2022, a decline of 0.9%[20] - The company's total liabilities increased, with current liabilities due within one year rising by 72.47% to ¥45,460,133.07[11] Operational Performance - The company's operating income decreased primarily due to a decline in the price and sales volume of photoinitiators[11] - The company reported a 38.08% decrease in cash received from sales of goods and services, totaling ¥116,123,483.59 compared to ¥187,553,033.14 in the previous year[12] - The company experienced a decline in orders and product prices due to global inflation and market competition, leading to a loss in Q1 2023[15] Other Income and Expenses - Other income increased significantly by 550.40% to ¥1,919,557.33, mainly due to an increase in government subsidies[12] - Research and development expenses for Q1 2023 were ¥10,335,803.87, down 15.6% from ¥12,251,077.27 in Q1 2022[21] - The company reported a credit impairment loss of ¥333,153.53 in Q1 2023, compared to a loss of ¥349,281.41 in Q1 2022[23] - Other comprehensive income after tax for Q1 2023 was ¥8,132,709.38, compared to a loss of ¥14,163,707.34 in Q1 2022[23] Market Outlook - The company is adjusting its production capacity based on market demand, with some products entering trial production[15] - The company anticipates a recovery in the downstream market supported by domestic and international trade openings and government policies[15]

浙江扬帆新材料股份有限公司2022年年度报告全文 浙江扬帆新材料股份有限公司 2022 年年度报告 【披露时间】 ...

一、说明会类型 证券代码：300637 证券简称：扬帆新材 公告编号：2023-016 浙江扬帆新材料股份有限公司 关于举行 2022 年度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 重要提示： 1、投资者可于 2023 年 4 月 28 日（星期五）15:00-17:00 访问业绩说明会页面 https://eseb.cn/140Mmm496Ok 在线参与，公司将及时回答投资者的提问。 2、投资者可于 2023 年 4 月 28 日（星期五）15:00 前将需要了解的情况和有关问 题预先通过电子邮件的形式发送至公司投资者关系邮箱，公司将会在说明会上对 投资者普遍关注的问题进行回答。 3、投资者可于 2023 年 4 月 28 日（星期五）15:00-17:00 通过扫描下方小程序码， 点击"进入会议"进行提问。公司将在本次说明会上，在信息披露允许范围内对 投资者普遍关注的问题进行重点回答。 本次说明会采用网络远程的方式举行，公司将针对 2022 年度的经营成果及 财务指标等具体情况与投资者互动交流，在信息披露规则允许的范围内就投资者 普 ...

证券代码：300637 证券简称：扬帆新材 编号：2017-1108-01 | --- | --- | --- | |----------------|-------------------------------|----------------------------------------------------------| | | | | | | □ | 特定对象调研 □分析师会议 | | | □ 媒体采访 □业绩说明会 | | | 投资者关系 | □ 新闻发布会 □路演活动 | | | 活动类别 | □ 现场参观 | | | | █ 其他 （机构调研） | | | 参与单位名称及 | 西南证券：黄景文； | | | 人员姓名（排名 | 东方证券资管：郭哲； | | | | 国联证券：吴程浩； | | | 不分大小前后） | 海通证券：刘海荣； | | | 时间 | 2017 年 11 月 08 | 日上午 9:30 至 11:30 | | 地点 | | 浙江省绍兴市杭州湾上虞经济技术开发区纬三路 25 号公司 | | | 会议室 | | | | 副总经理兼董事会秘书:李耀土； | | | 上市公司 ...

证券代码：300637 证券简称：扬帆新材 浙江扬帆新材料股份有限公司投资者关系活动记录表 编号：2018-002 | --- | --- | --- | |----------------|----------------------------|--------------------------------------------------------| | | | | | | □ | 特定对象调研 □分析师会议 | | | □媒体采访 □业绩说明会 | | | 投资者关系 | □ 新闻发布会 □路演活动 | | | 活动类别 | □现场参观 | | | | █ 其他 （机构调研） | | | 参与单位名称及 | 国泰君安证券 杨思远； | | | 人员姓名（排名 | 中泰证券 李海勇； | | | | 大成基金 韩创； | | | 不分大小前后） | 中融基金 寇文红； | | | 时间 | 14:00-15:15 | | | 地点 | 浙江省杭州市滨江区信诚路 | 31 号扬帆大厦 5 楼会议室 | | 上市公司接待 | 董事会秘书 樊相东； | | | 人员姓名 | 证券部 叶立群； | | | ...

Company Overview - The company reviewed its development history, current structure, main business, and operational model, along with the industry status of photoinitiators, including market capacity and competitive landscape [3] - The company highlighted its core competitiveness and the main risks it faces [3] Financial Performance - In Q1, the sales revenue of thiol compounds and photoinitiators increased, with thiol compounds accounting for over 50% and photoinitiators over 40% of total revenue [3] - The sales volume of photoinitiators grew by approximately 10%, with prices increasing by over 20% year-on-year [3] Pricing Dynamics - The price increase of photoinitiators is attributed to environmental regulations leading to the shutdown of intermediate production companies, resulting in supply shortages [4] - The market price for TPO photoinitiators has risen from around 100,000 CNY/ton to 200,000-300,000 CNY/ton, while 1173 has increased from 35,000 CNY/ton to 60,000 CNY/ton [4] Production Capacity and Expansion - Current production capacity still has room for expansion, with plans to adjust product structure based on market conditions [6] - The company aims for the Inner Mongolia project to reach 50%-70% of its designed production capacity by the third year [6] Profit Margins - The gross margin for thiol compounds has increased by approximately 10%, primarily due to high-margin products [7] - The gross margin for photoinitiators has also seen a year-on-year increase [7] Market Strategy - The company plans to maintain a balanced focus on both photoinitiators and thiol compounds, with significant market potential for both [8] - The company has established stable customer relationships and is actively communicating with clients regarding new product samples [9] Environmental and Cost Considerations - The company has invested approximately 30 million CNY in environmental protection measures over the years [11][12] - The cost of raw materials, electricity, and steam is lower in Inner Mongolia, providing a competitive advantage despite higher labor and transportation costs [11] Market Potential - The global market for photoinitiators is substantial, with the company's photoinitiator 907 accounting for 50%-60% of the market, yet its production volume is only about 2,000 tons, representing less than 1% of global usage [12] - The shift from solvent-based inks to water-based and UV-curable inks is expected to expand the market further [12]

证券代码：300637 证券简称：扬帆新材 浙江扬帆新材料股份有限公司投资者关系活动记录表 编号：2018-003 | --- | --- | --- | |----------------|----------------------------|------------------------------------| | | | | | | √ 特定对象调研 □分析师会议 | | | | □媒体采访 | □业绩说明会 | | 投资者关系 | □ 新闻发布会 □路演活动 | | | 活动类别 | □现场参观 | | | | □ 其他 | | | | 广发证券 | 吴鑫然； 太平洋证券 张波； | | | 中信证券 | 朱晓； 申万宏源 金铁桥； | | | 光大证券 | 徐亮、郭立胜； 富国基金 宋哲建； | | 参与单位名称及 | 国元证券 | 李朝松、毛正； 中融人寿 苗华； | | 人员姓名（排名 | 晖鸿投资 | 腾尧、叶啸剑； 茂典资产 唐忠杰； | | 不分大小前后） | 财通证券资管 | 邵沙锞； 松檀资本 徐彦锋； | | | 城投资本 | 包红政； 未来资产 王灵君； | | | 方际资 ...

Company Overview - The company has two production bases, one marketing company, and four R&D centers [3] - Main product series include thiol compounds and photoinitiators, with core competencies in full industry chain advantages and over 30 years of industry experience [3] Market Insights - The global demand for light-curing products was 533,000 tons in 2015, with the company holding a 50%-60% market share of the photoinitiator 907, equating to a production capacity of 2,000 tons [3][4] - The company anticipates an increase in production capacity to nearly 3,000 tons under ideal conditions [4] Pricing and Supply Dynamics - The price increase of photoinitiator 907 is attributed to rising upstream raw material costs, stricter environmental policies, and a decrease in market supply [4] - TPO prices rose from 100,000 CNY/ton to over 400,000 CNY/ton due to supply shortages from major suppliers [5][6] Future Projections - The Inner Mongolia project is expected to have a production capacity of 29,000 tons, including 11,000 tons of photoinitiators and 18,000 tons of pharmaceutical intermediates [6] - The market for TPO is estimated at 5,000 tons currently, with future capacity expected to reach around 8,000 tons [6] Shareholder Activity - The company disclosed that a shareholder plans to reduce holdings by no more than 2 million shares within the next six months [4] - Other shareholders have already reduced their stakes significantly, with some locked in for a period [4] Acquisition Strategy - The company is open to acquisitions in related industries, prioritizing those that align with its business model and offer synergistic benefits [5]

Revenue and Profit - Revenue for Q3 2022 reached ¥183,172,502.70, an increase of 16.39% compared to the same period last year[4] - Net profit attributable to shareholders was -¥2,216,767.80, a decrease of 24.17% year-on-year[4] - Net profit excluding non-recurring items was -¥2,566,464.94, down 8.22% from the previous year[4] - Total operating revenue for Q3 2022 reached CNY 593,054,621.33, an increase of 25.0% compared to CNY 474,651,935.08 in the same period last year[16] - Net profit attributable to shareholders of the parent company was CNY 11,137,965.35, a significant increase of 59.4% from CNY 6,995,118.84 in the previous year[18] - The total comprehensive income for the period was CNY 4,467,316.09, up from CNY 2,286,949.67, representing a growth of 95.5%[18] Cash Flow - Cash flow from operating activities for the year-to-date reached ¥79,825,795.82, a significant increase of 900.17%[4] - The cash inflow from operating activities for Q3 2022 was CNY 567,107,290.42, an increase from CNY 531,617,184.43 in Q3 2021, representing a growth of approximately 6.7%[21] - The net cash flow from operating activities was CNY 79,825,795.82, significantly higher than CNY 7,981,250.51 in the same period last year, indicating a substantial improvement[21] - The total cash outflow for operating activities was CNY 487,281,494.60, a decrease from CNY 523,635,933.92 in the previous year, showing a reduction of about 6.9%[21] - The company received CNY 60,396,322.01 in tax refunds, significantly higher than CNY 15,130,380.92 in Q3 2021, indicating improved cash flow from tax-related activities[21] Expenses - R&D expenses for the first nine months of 2022 totaled ¥32,407,174.17, up 54.87% year-on-year due to increased personnel and direct investment[9] - Sales expenses for the first nine months increased by 47.47% to ¥5,278,917.60, primarily due to higher marketing costs[9] - Research and development expenses increased to CNY 32,407,174.17, up 55.0% from CNY 20,925,926.31 in the same quarter last year[16] Assets and Liabilities - Total assets at the end of Q3 2022 were ¥1,372,789,233.05, a decrease of 1.91% from the end of the previous year[4] - Total current assets as of September 30, 2022, amount to ¥395,967,174.59, a decrease from ¥440,433,525.16 at the beginning of the year[14] - Total liabilities decreased to CNY 603,427,079.78 from CNY 633,451,884.66, reflecting a reduction of 4.0%[16] - The company's total equity increased slightly to CNY 769,362,153.27 from CNY 766,074,599.15, indicating a growth of 0.2%[16] Shareholder Information - Total number of common shareholders at the end of the reporting period is 13,660[10] - Zhejiang Yangfan Holding Group Co., Ltd. holds 23.69% of shares, totaling 55,606,200 shares, with 37,859,999 shares pledged[10] - SFC CO., LTD. holds 15.84% of shares, totaling 37,175,400 shares[10] Borrowings - Short-term borrowings increased by 35.80% to ¥333,405,805.05, reflecting a rise in financing needs[8] - Short-term borrowings as of September 30, 2022, amount to ¥333,405,805.05, an increase from ¥245,516,128.14[14] Inventory - Inventory as of September 30, 2022, is ¥206,224,736.53, an increase from ¥191,519,421.57[14] Investment Activities - The cash outflow from investing activities totaled CNY 93,730,832.59, down from CNY 168,435,032.78 in Q3 2021, reflecting a decrease of about 44.4%[21] - The net cash flow from investing activities was -CNY 70,401,329.50, an improvement compared to -CNY 113,390,161.26 in the previous year[21] - The company reported a cash inflow of CNY 23,300,000.00 from other investment activities, down from CNY 55,000,000.00 in Q3 2021, indicating a decrease of approximately 57.6%[21] Future Outlook - Future outlook and performance guidance were not explicitly mentioned in the provided content[11] - The company continues to focus on expanding its market presence and enhancing its product offerings through ongoing research and development initiatives[16]